BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17532764)

  • 1. The soluble transferrin receptor in dysplastic erythropoiesis in myelodysplastic syndrome.
    Metzgeroth G; Rosée PL; Kuhn C; Schultheis B; Dorn-Beineke A; Hehlmann R; Hastka J
    Eur J Haematol; 2007 Jul; 79(1):8-16. PubMed ID: 17532764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble transferrin receptor concentration is not superior to log ferritin for evaluating erythropoiesis in adolescents with iron deficiency anemia.
    Choi JW; Son BK
    Clin Chim Acta; 2005 May; 355(1-2):83-9. PubMed ID: 15820481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble transferrin receptor and zinc protoporphyrin--competitors or efficient partners?
    Metzgeroth G; Adelberger V; Dorn-Beineke A; Kuhn C; Schatz M; Maywald O; Bertsch T; Wisser H; Hehlmann R; Hastka J
    Eur J Haematol; 2005 Oct; 75(4):309-17. PubMed ID: 16146537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
    Wang W; Zhang MH; Yu Y; Xu CG
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytes.
    Musto P; Modoni S; Alicino G; Savino A; Longo A; Bodenizza C; Falcone A; D'Arena G; Scalzulli P; Perla G
    Haematologica; 1994; 79(6):493-9. PubMed ID: 7896207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble transferrin receptor and its ratio to erythroblasts in bone marrow may be a new diagnostic tool to distinguish between aplastic and refractory anemia.
    Matsuda A; Misumi M; Shimada T; Yoshida K; Yagasaki F; Ito Y; Kawai N; Murohashi I; Hirashima K; Bessho M
    Acta Haematol; 2004; 111(3):138-42. PubMed ID: 15034234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients.
    Chang J; Bird R; Clague A; Carter A
    Pathology; 2007 Jun; 39(3):349-53. PubMed ID: 17558864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of transfusional iron overload in patients with myelodysplastic syndrome or severe anemia: data from multicenter clinical practices.
    Raptis A; Duh MS; Wang ST; Dial E; Fanourgiakis I; Fortner B; Paley C; Mody-Patel N; Corral M; Scott J
    Transfusion; 2010 Jan; 50(1):190-9. PubMed ID: 19719471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum transferrin receptor.
    Skikne BS
    Am J Hematol; 2008 Nov; 83(11):872-5. PubMed ID: 18821709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro stimulation of erythropoiesis by stem cell factor alone in myelodysplastic syndrome patients with elevated endogenous erythropoietin serum levels.
    Zwierzina H; Bammer T; Rollinger-Holzinger I; Herold M; Fenaux P; Nüssler V; Hoflehner E; Geissler D
    Clin Cancer Res; 1996 Jun; 2(6):1031-8. PubMed ID: 9816264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of regulatory T cells in patients with myelodysplastic syndrome.
    Hamdi W; Ogawara H; Handa H; Tsukamoto N; Nojima Y; Murakami H
    Eur J Haematol; 2009 Mar; 82(3):201-7. PubMed ID: 19018862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited numbers of apoptotic cells in fresh paraffin embedded bone marrow samples of patients with myelodysplastic syndrome.
    Brada SJ; van de Loosdrecht AA; Koudstaal J; de Wolf JT; Vellenga E
    Leuk Res; 2004 Sep; 28(9):921-5. PubMed ID: 15234568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of erythropoiesis activity during hemodialysis therapy by soluble transferrin receptor levels and ferrokinetic measurements.
    Lorenzo JD; Rodríguez MM; Martín SS; Romo JM
    Am J Kidney Dis; 2001 Mar; 37(3):550-6. PubMed ID: 11228179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the erythropoiesis in myelodysplasia by means of ferrokinetic studies, in vitro erythroid colony formation and soluble transferrin receptor.
    Brada SJ; de Wolf JT; Hendriks D; Louwes H; van den Berg E; Vellenga E
    Leukemia; 1998 Mar; 12(3):340-5. PubMed ID: 9529128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity, specificity, and predictive value of serum soluble transferrin receptor at different stages of iron deficiency.
    Choi JW
    Ann Clin Lab Sci; 2005; 35(4):435-9. PubMed ID: 16254261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythroid bone marrow activity and red cell hemoglobinization in iron sufficient beta-thalassemia heterozygotes as reflected by soluble transferrin receptor and reticulocyte hemoglobin in content. Correlation with genotypes and Hb A(2) levels.
    Skarmoutsou C; Papassotiriou I; Traeger-Synodinos J; Stamou H; Ladis V; Metaxotou-Mavrommati A; Stamoulakatou A; Kanavakis E
    Haematologica; 2003 Jun; 88(6):631-6. PubMed ID: 12801838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
    Balleari E; Rossi E; Clavio M; Congiu A; Gobbi M; Grosso M; Secondo V; Spriano M; Timitilli S; Ghio R
    Ann Hematol; 2006 Mar; 85(3):174-80. PubMed ID: 16408206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum transferrin receptor in healthy children].
    Vázquez López MF; Carracedo Morales A; Muñoz Vico J; Morcillo Llorens R; Calvo Bonachera MD; López Muñoz J; Muñoz Hoyos A
    An Esp Pediatr; 2001 Aug; 55(2):113-20. PubMed ID: 11472662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypochromic red blood cells in low-risk myelodysplastic syndromes: effects of treatment with hemopoietic growth factors.
    Ljung T; Bäck R; Hellström-Lindberg E
    Haematologica; 2004 Dec; 89(12):1446-53. PubMed ID: 15590394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between serum transferrin receptor concentrations and erythropoietic activities according to body iron status.
    Choi JW; Pai SH
    Ann Clin Lab Sci; 2003; 33(3):279-84. PubMed ID: 12956442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.